Cargando…

Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma

The prognosis for newly diagnosed subjects with multiple myeloma (MM) has significantly progressed in recent years. However, most MM patients relapse and after several salvage therapies, the onset of multidrug resistance provokes the occurrence of a refractory disease. A continuous and bidirectional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allegra, Alessandro, Ettari, Roberta, Innao, Vanessa, Bitto, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923438/ https://www.ncbi.nlm.nih.gov/pubmed/33672466 http://dx.doi.org/10.3390/cells10020448

Ejemplares similares

Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
por: Innao, Vanessa, et al.
Publicado: (2021)

Recent Advances in Nanotherapeutics for Multiple Myeloma
por: Iannazzo, Daniela, et al.
Publicado: (2020)

Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications
por: Allegra, Alessandro, et al.
Publicado: (2023)

Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
por: Musolino, Caterina, et al.
Publicado: (2017)

Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient
por: Innao, Vanessa, et al.
Publicado: (2017)

Monoclonal Antibodies: The Greatest Resource to Treat Multiple Myeloma
por: De Luca, Fabiola, et al.
Publicado: (2023)

Role of micro-RNAs in drug resistance of multiple myeloma
por: Abdi, Jahangir, et al.
Publicado: (2016)

Circulating microRNAs and Their Role in Multiple Myeloma
por: Federico, Cinzia, et al.
Publicado: (2019)

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019)

MicroRNAs: New Players in Multiple Myeloma
por: Pichiorri, Flavia, et al.
Publicado: (2011)

MicroRNAs in urine are not biomarkers of multiple myeloma
por: Sedlaříková, Lenka, et al.
Publicado: (2015)

Formaldehyde Exposure and Acute Myeloid Leukemia: A Review of the Literature
por: Allegra, Alessandro, et al.
Publicado: (2019)

The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma
por: Zhu, Bingying, et al.
Publicado: (2018)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019)

Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
por: Rastgoo, Nasrin, et al.
Publicado: (2017)

Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma
por: Soliman, Amro M., et al.
Publicado: (2020)

MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
por: Desantis, Vanessa, et al.
Publicado: (2020)

Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma
por: Zhang, Wenjing, et al.
Publicado: (2014)

Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells
por: Ettari, Roberta, et al.
Publicado: (2019)

Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw
por: Allegra, Alessandro, et al.
Publicado: (2020)

Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
por: Innao, Vanessa, et al.
Publicado: (2020)

Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma
por: Allegra, Alessandro, et al.
Publicado: (2021)

MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease
por: Desantis, Vanessa, et al.
Publicado: (2021)

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012)

Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions
por: Moura, Sara Reis, et al.
Publicado: (2021)

Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
por: Zhang, Li, et al.
Publicado: (2016)

Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma
por: Zelli, Veronica, et al.
Publicado: (2022)

New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
por: Innao, Vanessa, et al.
Publicado: (2020)

Air Pollution and microRNAs: The Role of Association in Airway Inflammation
por: Furci, Fabiana, et al.
Publicado: (2023)

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions
por: Alzrigat, Mohammad, et al.
Publicado: (2016)

Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

Interactions between the MicroRNAs and Microbiota in Cancer Development: Roles and Therapeutic Opportunities
por: Allegra, Alessandro, et al.
Publicado: (2020)

Extracellular Vesicle microRNAs Contribute to the Osteogenic Inhibition of Mesenchymal Stem Cells in Multiple Myeloma
por: Raimondo, Stefania, et al.
Publicado: (2020)

Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells
por: Mannino, Federica, et al.
Publicado: (2021)

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
por: Allegra, Alessandro, et al.
Publicado: (2020)

The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma
por: Handa, Hiroshi, et al.
Publicado: (2019)

microRNAs: a role in drug resistance in parasitic nematodes?
por: Devaney, Eileen, et al.
Publicado: (2010)

The role and mechanisms of action of microRNAs in cancer drug resistance
por: Si, Wengong, et al.
Publicado: (2019)

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma
por: Bi, Chonglei, et al.
Publicado: (2015)

Theranostic Applications of 2D Graphene-Based Materials for Solid Tumors Treatment
por: Iannazzo, Daniela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9uarapaen6q60qoel9c4mbv43b